Correlation Between Virax Biolabs and Kiora Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Kiora Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Kiora Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Kiora Pharmaceuticals, you can compare the effects of market volatilities on Virax Biolabs and Kiora Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Kiora Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Kiora Pharmaceuticals.
Diversification Opportunities for Virax Biolabs and Kiora Pharmaceuticals
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Virax and Kiora is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Kiora Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiora Pharmaceuticals and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Kiora Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiora Pharmaceuticals has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Kiora Pharmaceuticals go up and down completely randomly.
Pair Corralation between Virax Biolabs and Kiora Pharmaceuticals
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 2.1 times more return on investment than Kiora Pharmaceuticals. However, Virax Biolabs is 2.1 times more volatile than Kiora Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Kiora Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest 218.00 in Virax Biolabs Group on August 30, 2024 and sell it today you would lose (11.00) from holding Virax Biolabs Group or give up 5.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Kiora Pharmaceuticals
Performance |
| Timeline |
| Virax Biolabs Group |
| Kiora Pharmaceuticals |
Virax Biolabs and Kiora Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Kiora Pharmaceuticals
The main advantage of trading using opposite Virax Biolabs and Kiora Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Kiora Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiora Pharmaceuticals will offset losses from the drop in Kiora Pharmaceuticals' long position.| Virax Biolabs vs. Ikena Oncology | Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. RenovoRx |
| Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |